dexter_info: model=gpt-5.2 iterations=3 tool_calls=4
{
  "run_date": "2026-02-12",
  "fund_name": "Quality + Momentum (Monthly-hold)",
  "paper_only": true,
  "market_summary": [
    "Broad risk-off tape in mega-cap growth today: AAPL -4.75%, AMZN -2.11%, META -2.19%, AVGO -2.78% (price snapshots 2026-02-12).",
    "Defensive/quality areas held up better in this slice: WMT +2.50%, COST +1.96%, LLY +2.21%, UNH +1.53% (price snapshots 2026-02-12).",
    "Notable single-name catalyst in the last 72h among retrieved items: MRK reported as receiving an FDA approval expansion for Keytruda (news 2026-02-11)."
  ],
  "thesis_damage_flags": [
    {
      "ticker": "SBUX",
      "why": "Negative headline risk: article flagging potential dividend cut in 2026 (news 2026-02-11). Not in target portfolio after todayâ€™s action."
    },
    {
      "ticker": "AAPL",
      "why": "Large single-day drawdown (-4.75% on 2026-02-12 snapshot) increases near-term momentum risk; no verified 72h company-specific catalyst retrieved in provided data."
    },
    {
      "ticker": "MS",
      "why": "Large single-day drawdown (-5.78% on 2026-02-12 snapshot) increases near-term momentum risk; no verified 72h company-specific catalyst retrieved in provided data."
    },
    {
      "ticker": "GS",
      "why": "Large single-day drawdown (-4.89% on 2026-02-12 snapshot) increases near-term momentum risk; no verified 72h company-specific catalyst retrieved in provided data."
    }
  ],
  "trade_of_the_day": {
    "action": "Replace",
    "remove_ticker": "MO",
    "add_ticker": "MRK",
    "size_change_pct": 0,
    "thesis": [
      "MRK has a verified near-term fundamental catalyst: report of FDA approval expanding Keytruda use in pretreated ovarian cancer patients (Benzinga, 2026-02-11).",
      "Quality + durability profile: large-cap Health Care pharma with diversified pipeline exposure (sector/facts verified; market cap ~296.1B as of 2026-02-12 company facts).",
      "Improves portfolio balance versus adding more rate/credit sensitive Financials or higher-beta mega-cap Tech on a down day (todayâ€™s snapshots show several growth leaders down 2â€“5%)."
    ],
    "risks": [
      "Headline may not translate into meaningful revenue/earnings uplift if label expansion has limited uptake or reimbursement friction (impact UNKNOWN from provided data).",
      "Regulatory/clinical setbacks elsewhere in the portfolio could offset the positive catalyst (pipeline details UNKNOWN from provided data).",
      "Sector rotation risk: if risk-on resumes sharply, defensive pharma could underperform higher beta names over a 30-day window."
    ],
    "falsifiable_checks": [
      "If subsequent verified news within the next 30 days indicates the Keytruda label expansion is delayed, restricted, or challenged, treat as thesis failure.",
      "If MRK exhibits persistent relative weakness versus defensive peers (e.g., UNH/LLY) over the next 30 days despite no negative verified catalysts, reduce confidence in momentum fit."
    ],
    "why_now": "Over the next 6â€“18 months, market leadership often rewards companies with durable franchises plus identifiable catalysts. The retrieved, time-stamped FDA approval headline provides a concrete catalyst to anchor a Health Care allocation while maintaining quality bias, and it diversifies away from Consumer Staples Tobacco (MO) where long-term growth is structurally challenged (quantified impact UNKNOWN in provided data)."
  },
  "target_portfolio": [
    {
      "ticker": "MSFT",
      "weight_pct": 10,
      "sector": "Information Technology"
    },
    {
      "ticker": "AAPL",
      "weight_pct": 8,
      "sector": "Information Technology"
    },
    {
      "ticker": "AVGO",
      "weight_pct": 7,
      "sector": "Information Technology"
    },
    {
      "ticker": "GOOGL",
      "weight_pct": 8,
      "sector": "Communication Services"
    },
    {
      "ticker": "AMZN",
      "weight_pct": 8,
      "sector": "Consumer Discretionary"
    },
    {
      "ticker": "JPM",
      "weight_pct": 9,
      "sector": "Financials"
    },
    {
      "ticker": "MA",
      "weight_pct": 8,
      "sector": "Financials"
    },
    {
      "ticker": "UNH",
      "weight_pct": 8,
      "sector": "Health Care"
    },
    {
      "ticker": "MRK",
      "weight_pct": 8,
      "sector": "Health Care"
    },
    {
      "ticker": "LLY",
      "weight_pct": 9,
      "sector": "Health Care"
    },
    {
      "ticker": "WMT",
      "weight_pct": 8,
      "sector": "Consumer Staples"
    },
    {
      "ticker": "CAT",
      "weight_pct": 9,
      "sector": "Industrials"
    }
  ],
  "constraints_check": {
    "max_position_ok": true,
    "max_sector_ok": true,
    "notes": "12 holdings; all weights >0 and <=12; total=100. Sector weights: IT=25 (MSFT 10 + AAPL 8 + AVGO 7), Health Care=25 (UNH 8 + MRK 8 + LLY 9), Financials=17 (JPM 9 + MA 8), Communication Services=8 (GOOGL 8), Consumer Discretionary=8 (AMZN 8), Consumer Staples=8 (WMT 8), Industrials=9 (CAT 9). Max sector exposure equals 25% (within limit)."
  }
}
